Ultragenyx Pharmaceutical RARE Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's shares (basic)?
- Ultragenyx Pharmaceutical (RARE) reported shares (basic) of 100.6M in Q1 2026.
- How has Ultragenyx Pharmaceutical's shares (basic) changed year-over-year?
- Ultragenyx Pharmaceutical's shares (basic) increased by 4.5% year-over-year, from 96.3M to 100.6M.
- What is the long-term trend for Ultragenyx Pharmaceutical's shares (basic)?
- Over 3 years (2022 to 2025), Ultragenyx Pharmaceutical's shares (basic) has grown at a 12.1% compound annual growth rate (CAGR), from 279.4M to 393.1M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.